Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort ascending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort ascending Functional Area Erscheinungsdatum
MR Beijing (Beijing) China International Innovative Medicines Der Umsatz Sep 01, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Corporate Affairs Innovative Medicines Einrichtungen und Verwaltung Sep 02, 2024
Validation Expert İstanbul Kurtköy Türkei Operations Innovative Medicines Technical Operations Sep 03, 2024
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Deutschland International Innovative Medicines Research & Development Sep 06, 2024
Senior QC Specialist Kundl Österreich Operations Innovative Medicines Quality Sep 09, 2024
Clinical Development Medical Director East Hanover USA Development Innovative Medicines Research & Development Apr 24, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Head of Quality Carlsbad USA Operations Innovative Medicines Quality Sep 03, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 29, 2024
Maintenance & Calibration Technician (2nd shift) Millburn USA Operations Innovative Medicines Technical Operations Apr 29, 2024
Oncology Specialist - RLT- Portland- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Der Umsatz Apr 29, 2024
MR Beijing (Beijing) China International Innovative Medicines Der Umsatz Apr 29, 2024
Area Marketing Manager Chengdu (Sichuan Province) China International Innovative Medicines Marketing Apr 30, 2024
(高级)区域市场经理 Zhengzhou (Henan Province) China International Innovative Medicines Marketing Apr 30, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines Der Umsatz Apr 30, 2024
Commissioning & Qualification (C&Q) Engineering Lead (RLT, Carlsbad) Remote Position (USA) USA Operations Innovative Medicines Technical Operations Apr 30, 2024
Product manager (Hematology) Moscow (City) Russische Foed. International Innovative Medicines Marketing Mai 02, 2024
Process Specialist İstanbul Kurtköy Türkei Operations Innovative Medicines Technical Operations Sep 03, 2024
Sr. Process Team Lead İstanbul Kurtköy Türkei Operations Innovative Medicines Technical Operations Sep 03, 2024
Senior Clinical Research Associate, Western Region Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Mai 03, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Der Umsatz Mai 06, 2024
Area Marketing Manager Wuhan (Hubei Province) China International Innovative Medicines Marketing Mai 06, 2024
Maintenance Technician (Instrumentation) Schaftenau Österreich Operations Innovative Medicines Technical Operations Mai 09, 2024
Clinical Development Medical Director, Urology East Hanover USA Development Innovative Medicines Research & Development Mai 09, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development Mai 10, 2024
Ekspert tehnologije izdelkov (m/ž/d) / Product Steward (m/f/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Mai 10, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Der Umsatz Mai 15, 2024
Global Program Clinical Head: In-market Brands London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 18, 2024
Senior Expert, Science & Technology - Potency East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Executive Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Der Umsatz Sep 18, 2024
Senior Expert Data Science Hyderabad (Office) Indien Operations Innovative Medicines Data and Digital Sep 18, 2024
Senior Principal Product Operations Manager Hyderabad (Office) Indien Biomedical Research Innovative Medicines Research & Development Sep 19, 2024
Senior Principal Statistical Programmer - Advanced Quantitative Sciences East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Associate Director, Statistical Programming East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Head of Data Driven Decision Making New South Wales (NSW) Australien International Innovative Medicines Marketing Sep 19, 2024
Analyst Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 20, 2024
KAM/Senior KAM - Oncology - North London Field Force (England / Wales) Vereinigtes Königreich International Innovative Medicines Der Umsatz Sep 20, 2024
Digital Strategy & Insights Manager (f/m/d) Vienna Österreich International Innovative Medicines Marketing Sep 20, 2024
Brand manager - Oncology (m/f/d) / Vodja blagovne znamke v onkologiji (m/ž/d) Ljubljana Slowenien International Innovative Medicines Marketing Sep 20, 2024
Clinical Development Medical Director - Renal **80-100% Basel (City) Schweiz Development Innovative Medicines Research & Development Sep 20, 2024
Global Program Clinical Head - CRM Basel (City) Schweiz Development Innovative Medicines Research & Development Sep 20, 2024
Tehnolog proizvodnih procesov II (ž/m/d)/Process Expert II (f/m/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Sep 22, 2024
Tehnolog proizvodnih procesov II (ž/m/d)/Process Expert II (f/m/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Sep 22, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Der Umsatz Sep 23, 2024
Tehnolog proizvodnih procesov II (ž/m/d)/Process Expert II (f/m/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Sep 24, 2024
Patient Support Program Lead Seoul Südkorea International Innovative Medicines Marketing Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.